Capital expenditure increased 46.4%
Capital expenditure changed +46.4% from the comparable as-filed period.
$261.4M→$382.7M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DKS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 574 bp lower
Free-cash-flow margin changed -574 basis points from the comparable as-filed period.
8.12%→2.38%2 prior comparisons
Operating cash-flow margin moved 606 bp lower
Operating cash-flow margin changed -606 basis points from the comparable as-filed period.
15.29%→9.23%2 prior comparisons
Working capital / assets moved 630 bp lower
Working capital / assets changed -630 basis points from the comparable as-filed period.
19.40%→13.10%3 prior comparisons
Stock-based compensation increased 27.8%
Stock-based compensation changed +27.8% from the comparable as-filed period.
$18.8M→$24.0M3 prior comparisons
Operating cash flow decreased 7.5%
Operating cash flow changed -7.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$557.6M→$515.8M3 prior comparisons
Working capital increased 15.2%
Working capital changed +15.2% from the comparable as-filed period.
$2.1B→$2.4B3 prior comparisons
Capex / revenue moved 32 bp lower
Capex / revenue changed -32 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.17%→6.85%2 prior comparisons
Operating income decreased 2.5%
Operating income changed -2.5% from the comparable as-filed period.
$452.2M→$440.8M2 prior comparisons
Current ratio decreased 12.5%
Current ratio changed -12.5% from the comparable as-filed period.
1.7→1.483 prior comparisons
SBC / revenue moved 9 bp lower
SBC / revenue changed -9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.51%→0.43%2 prior comparisons
Capital expenditure increased 36.3%
Capital expenditure changed +36.3% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
$264.7M→$360.7M6 prior comparisons
Net income increased 21.0%
Net income changed +21.0% from the comparable as-filed period.
$264.3M→$319.8M0 prior comparisons
Capex / revenue moved 135 bp lower
Capex / revenue changed -135 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
8.34%→6.99%2 prior comparisons
Free-cash-flow proxy increased 2.8%
Free-cash-flow proxy changed +2.8% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
-$86.7M→-$84.2M6 prior comparisons
SBC / revenue moved 3 bp lower
SBC / revenue changed -3 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.60%→0.58%2 prior comparisons
Cash & equivalents decreased 3.6%
Cash & equivalents changed -3.6% from the comparable as-filed period.
$1.0B→$998.2M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.